Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-015284

Chief Operating Officer sold 42,500 shares at $19.99 ($849,575)

  • Chief Operating Officer acquired 42,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-03-01 Option exercise +42,500 $2.01 $85,425 687,106 D
GIVEN BRUCE D Chief Operating Officer 2019-03-01 Sale −42,500 $19.99 $849,575 644,606 D
Derivatives
GIVEN BRUCE D Chief Operating Officer 2019-03-01 Option exercise · Stock Option (right to buy) −42,500 350,000 D
Open-market sales · 42,500 sh · avg $19.99 · $849,575
Loading xslF345X03/doc4.xml…